| Preferred Name |
betrixaban |
| Synonyms |
PRT054021 |
| ID |
http://purl.bioontology.org/ontology/MESH/C543086 |
| altLabel |
PRT054021 N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide BEVYXXA |
| cui |
C2743196 C2698385 C4490271 |
| HM |
D001549 D011725 |
| Inverse of RB |
74RWP7W0J9 |
| isa | |
| LT |
TRD |
| Mapped to | |
| MDA |
20090825 |
| MeSH Frequency |
86 |
| MMR |
20170626 |
| notation |
C543086 |
| PA |
D065427 |
| prefLabel |
betrixaban |
| SC |
1 |
| Scope Statement |
a highly potent, selective, and orally efficacious factor Xa inhibitor; structure in first source |
| SRC |
Bioorg Med Chem Lett. 2009 Apr 15;19(8):;2179-85 |
| TERMUI |
T756731 T756732 T000927873 T756733 |
| TH |
NLM (2017) FDA SRS (2013) USAN (19XX) NLM (2009) INN (19XX) |
| tui |
T109 T121 |